Determinants of generic and specific healthrelated quality of life in patients with Parkinson's disease

被引:24
|
作者
Tu, Xiao-Jing [1 ]
Hwang, Wen-Juh [2 ]
Ma, Hui-Ing [1 ,3 ]
Chang, Ling-Hui [1 ,3 ]
Hsu, Shih-Pin [4 ,5 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Dept Neurol, Coll Med, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan, Taiwan
[4] E Da Hosp, Dept Neurol, Kaohsiung, Taiwan
[5] I Shou Univ, Kaohsiung, Taiwan
来源
PLOS ONE | 2017年 / 12卷 / 06期
关键词
MDS-UPDRS; NONMOTOR SYMPTOMS; CHINESE VERSION; RATING-SCALES; DISORDER; VALIDATION; CRITIQUE; PROGRESSION; IMPACT;
D O I
10.1371/journal.pone.0178896
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Generic and disease-specific health-related quality of life (HRQoL) instruments may reflect different aspects of lives in patients with Parkinson's disease (PD) and thus be associated with different determinants. We used the same cluster of predictors for the generic and disease- specific HRQoL instruments to examine and compare the determinants of HRQoL. Method HRQoL was measured in 92 patients with PD by the 36-item Short-Form Health Survey (SF-36) and the 39-item Parkinson's Disease Questionnaire (PDQ-39). The predictors included demographic and disease characteristics, and motor and non-motor symptoms. Multiple regression analyses were used to identify HRQoL determinants. Results Depressive symptoms and motor difficulties of daily living were the first two significant determinants for both instruments. The other significant determinant for the SF-36 was fatigue and non-motor difficulties of daily living, and for the PDQ-39 was motor signs of PD. Conclusions The results suggest the importance of the evaluation and intervention focused on depressive symptoms and motor difficulties of daily living in patients with PD. In addition, the SF-36 seems more related to non-motor symptoms, while the PDQ-39 appears more associated with motor symptoms. This information is important for understanding results from these two instruments and for choosing which to use.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Determinants of quality of life in Brazilian patients with Parkinson's disease
    Carod-Artal, Francisco Javier
    Vargas, Antonio Pedro
    Martinez-Martin, Pablo
    MOVEMENT DISORDERS, 2007, 22 (10) : 1408 - 1415
  • [2] NUTRITIONAL DETERMINANTS OF QUALITY OF LIFE IN PATIENTS WITH PARKINSON'S DISEASE
    Lopez Botello, C. K.
    Castillo Torres, S. A.
    Martinez-Roque, D.
    Duarte-Bravo, J.
    Estrada-Bellmann, I. E.
    Chavez-Luevanos, B.
    Ancer Rodriguez, P. R.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E49 - E49
  • [3] The determinants of quality of life in Parkinson's disease
    Schrag, A
    MOVEMENT DISORDERS, 2002, 17 : S12 - S12
  • [4] Pramipexole versus levodopa in patients with early Parkinson's disease: Effect on generic and disease-specific quality of life
    Noyes, K
    Dick, AW
    Holloway, RG
    VALUE IN HEALTH, 2006, 9 (01) : 28 - 38
  • [5] Determinants of quality of life in a large, online cohort of patients with Parkinson's disease
    Bock, M.
    Brown, E.
    Tanner, C.
    MOVEMENT DISORDERS, 2020, 35 : S558 - S558
  • [6] Determinants of quality of life in Parkinson disease
    Kertelge, L.
    Brueggemann, N.
    Schmidt, A.
    Tadic, V.
    Wisse, C.
    Drude, L.
    Schneider, S. A.
    van der Vegt, J.
    Siebner, H.
    Lohmann, K.
    Buhmann, C.
    Hagenah, J.
    Klein, C.
    Kasten, M.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S64 - S64
  • [7] Determinants and impact of alexithymia on quality of life in Parkinson's disease
    Alvarado-Bolanos, A.
    Cervantes-Arriaga, A.
    Zuazua-Vidal, L.
    Esquivel-Zapata, O.
    Alcocer-Salas, A.
    Rodriguez-Violante, M.
    NEUROLOGIA, 2023, 38 (05):
  • [8] Generic and Disease-Specific Measures of Quality of Life in Patients with Mild Alzheimer's Disease
    Bhattacharya, Suvosree
    Vogel, Asmus
    Hansen, Marie-Louise H.
    Waldorff, Frans B.
    Waldemar, Gunhild
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2010, 30 (04) : 327 - 333
  • [9] The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP)
    He, Lu
    Lee, Eun-Young
    Sterling, Nicholas W.
    Kong, Lan
    Lewis, Mechelle M.
    Du, Guangwei
    Eslinger, Paul J.
    Huang, Xuemei
    JOURNAL OF PARKINSONS DISEASE, 2016, 6 (03) : 523 - 532
  • [10] Quality of life of patients with Parkinson's disease
    Khouadja, S.
    Melki, R.
    Younes, S.
    Betbout, I.
    Younes, S.
    Hidouri, B.
    Zarrouk, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S436 - S436